(Q47200742)

11 January 2018

title

Treatment of acute pulmonary embolism by a low molecular weight heparin fraction. A preliminary study (English)

1 reference

11 January 2018

1 reference

Y Huet

1

1 reference

11 January 2018

M Gouault-Heilmann

series ordinal

2

1 reference

11 January 2018

G Contant

series ordinal

3

1 reference

11 January 2018

C Brun-Buisson

series ordinal

4

1 reference

11 January 2018

publication date

1 January 1987

1 reference

11 January 2018

published in

Intensive Care Medicine

1 reference

11 January 2018

volume

13

1 reference

11 January 2018

issue

2

1 reference

11 January 2018

page(s)

126-130

1 reference

11 January 2018

https://scigraph.springernature.com/pub.10.1007/bf00254798

exact match

0 references

cites work

Cardiopulmonary bypass with a low-molecular-weight heparin fraction

1 reference

12 December 2020

Spontaneous fibrinolysis in pulmonary embolism

1 reference

12 December 2020

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

1 reference

12 December 2020

Some Guidelines for Heparin Therapy of Venous Thromboembolic Disease

1 reference

12 December 2020

Recovery of Pulmonary Arterial Blood Flow in Patients with Pulmonary Embolism

1 reference

12 December 2020

Molecular weight dependence of the anticoagulant properties of heparin: intravenous and subcutaneous administration of fractionated heparins to man

1 reference

12 December 2020

Randomized prospective trial of continuous vs intermittent heparin therapy

1 reference

12 December 2020

A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation

1 reference

12 December 2020

Effect of Heparin and Heparin Fractions on Platelet Aggregation

1 reference

12 December 2020

Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis

1 reference

12 December 2020

Heparin in the prophylaxis and treatment of venous thromboembolism

1 reference

12 December 2020

Inferior vena cava interruption in the management of pulmonary embolism

1 reference

12 December 2020

Haemorrhagic complications of heparin therapy

1 reference

12 December 2020

The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits

1 reference

12 December 2020

Management of heparin therapy: Controlled prospective trial

1 reference

12 December 2020

Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial

1 reference

12 December 2020

Use of low-molecular-weight heparin in heparin-induced thrombocytopenia with thrombotic complications

1 reference

12 December 2020

Resolution rate of acute pulmonary embolism in man.

1 reference

12 December 2020

Prevention of post-operative venous thromboembolism by a new low molecular weight heparin fraction

1 reference

12 December 2020

Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin

1 reference

12 December 2020

Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole-C.T.A.D. mixture

1 reference

12 December 2020

The urokinase pulmonary embolism trial. A national cooperative study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00254798

1 reference

11 January 2018

PubMed ID

3571712

1 reference

11 January 2018